Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Strategic Buy Lights Up This Biotech Stock: Time to Invest?: https://www.marketbeat.com/logos/articles/med_20240715092117_chartm-ilmn.jpg
Strategic Buy Lights Up This Biotech Stock: Time to Invest?

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of

Strategic Buy Lights Up This Biotech Stock: Time to Invest?: https://www.marketbeat.com/logos/articles/med_20240715092117_chartm-ilmn.jpg
Strategic Buy Lights Up This Biotech Stock: Time to Invest?

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of

Strategic Buy Lights Up This Biotech Stock: Time to Invest?: https://www.marketbeat.com/logos/articles/med_20240715092117_chartm-ilmn.jpg
Strategic Buy Lights Up This Biotech Stock: Time to Invest?

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of

Top 4 Must-Have Healthcare Stocks for Long-Term Growth: https://www.marketbeat.com/logos/articles/med_20240711100558_top-4-must-have-healthcare-stocks-for-long-term-gr.jpg
Top 4 Must-Have Healthcare Stocks for Long-Term Growth

The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging

Top 4 Must-Have Healthcare Stocks for Long-Term Growth: https://www.marketbeat.com/logos/articles/med_20240711100558_top-4-must-have-healthcare-stocks-for-long-term-gr.jpg
Top 4 Must-Have Healthcare Stocks for Long-Term Growth

The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging

Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market

Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. Mounjaro is prescribed for Type 2 diabetes but is

HealthEquity Stock: Leading Health Savings Account Investment
HealthEquity Stock: Leading Health Savings Account Investment

HealthEquity Inc (NASDAQ: HQY) is one of the nation’s largest providers of health savings accounts (HSA) and consumer-directed benefits (CDB) services. Its platform enables individuals to open

Centene Reaffirms Guidance, But Is it Too Late?
Centene Reaffirms Guidance, But Is it Too Late?

Managed care health insurance company Centene Inc. (NYSE: CNC) recently saw its share rebound after reaffirming its guidance. This move came just after UnitedHealth Group Inc. (NYSE: UNH) made

Is Cigna Group the Nation's Best-Run Health Insurance Company?
Is Cigna Group the Nation's Best-Run Health Insurance Company?

Health insurance companies in the medical sector have not fared well in 2024. Medicare Advantage (MA) plans were a bountiful source of income until the second half of 2023. Humana Inc. (NYSE: HUM)

Medtronic Dips: Is Now the Time to Buy?
Medtronic Dips: Is Now the Time to Buy?

Shares of Medtronic (NYSE: MDT) are falling following its FQ4 release and guidance, opening up a potential buying opportunity. The question is whether its value, yield, balance sheet and cash flow

2 Stocks Providing Medical Insurance for Your Pets
2 Stocks Providing Medical Insurance for Your Pets

The pandemic triggered a surge in pet ownership as social distancing and lockdowns resulted in the need for companionship for many individuals and families. Anyone who owns a dog or cat can

Undervalued UnitedHealth Group Won’t Be For Long
Undervalued UnitedHealth Group Won’t Be For Long

UnitedHealth Group's (NYSE: UNH) Q1 results were better than expected for two reasons: First, the stock price is now rebounding from long-term lows and deep value territory with ample upside

Undervalued UnitedHealth Group Won’t Be For Long
Undervalued UnitedHealth Group Won’t Be For Long

UnitedHealth Group's (NYSE: UNH) Q1 results were better than expected for two reasons: First, the stock price is now rebounding from long-term lows and deep value territory with ample upside

Novo Nordisk Arms Wegovy to Be a Triple Threat
Novo Nordisk Arms Wegovy to Be a Triple Threat

Ozempic usage for weight loss has gone viral, making it the highest revenue-generating drug for Novo Nordisk AV/S (NYSE: NVO). Originally purposed for Type 2 diabetes, the skyrocketing off-label

DexCom Stock Gains from GLP-1 Diabetic Users
DexCom Stock Gains from GLP-1 Diabetic Users

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People with diabetes use CGM systems to

DexCom Stock Gains from GLP-1 Diabetic Users
DexCom Stock Gains from GLP-1 Diabetic Users

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People with diabetes use CGM systems to

Medtronic is a Dividend Aristocrat That Keeps Gaining
Medtronic is a Dividend Aristocrat That Keeps Gaining

Medical device maker Medtronic PLC (NYSE: MDT) is a Dividend Aristocrat in the medical and healthcare sectors. The medical device maker has raised its dividend payout for 46 consecutive years

Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?
Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?

UnitedHealth Group Inc. (NYSE: UNH) has given up almost all of its 12-month gains in the last week after two unrelated incidents have rocked the company. At the close of trading on March 1, 2024

Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?
Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?

UnitedHealth Group Inc. (NYSE: UNH) has given up almost all of its 12-month gains in the last week after two unrelated incidents have rocked the company. At the close of trading on March 1, 2024

Can UnitedHealth Group afford to keep Medicare Advantage plans?
Can UnitedHealth Group afford to keep Medicare Advantage plans?

Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit

Can UnitedHealth Group afford to keep Medicare Advantage plans?
Can UnitedHealth Group afford to keep Medicare Advantage plans?

Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit

Why Cigna stock will be at fresh highs by March
Why Cigna stock will be at fresh highs by March

The Cigna Group’s (NYSE: CI) 35% rally that started last summer just hit a new high gear. While investors would have been spooked by the 20% slide from November into December, all that damage has

Is Humana’s pain HCA Healthcare’s gain?
Is Humana’s pain HCA Healthcare’s gain?

HCA Healthcare Inc. (NYSE: HCA) is the largest for-profit hospital company in the United States. The company owns and operates 186 hospitals and nearly 2,400 ambulatory sites, including

Med-tech stock Conmed dips ahead of big Q4 report...opportunity?
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?

When Utica, NY-based medical technology company CONMED Corporation (NYSE:CNMD) reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in

4 med tech stocks with improving prognosis for 2024
4 med tech stocks with improving prognosis for 2024

Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to